Cancer News and Research

Latest Cancer News and Research

Single-dose radiotherapy effectively reduces spinal cord compression symptoms

Single-dose radiotherapy effectively reduces spinal cord compression symptoms

Testicular cancer survivors with low testosterone more likely to have chronic health problems

Testicular cancer survivors with low testosterone more likely to have chronic health problems

Psychological intervention reduces fear of recurrence in breast cancer survivors

Psychological intervention reduces fear of recurrence in breast cancer survivors

Cannabinoids used in combination with chemotherapy found to be effective in killing leukemia cells

Cannabinoids used in combination with chemotherapy found to be effective in killing leukemia cells

Novartis to collaborate with IBM Watson Health for improving outcomes in advanced breast cancer

Novartis to collaborate with IBM Watson Health for improving outcomes in advanced breast cancer

Symptom self-reporting web-based tool could be used to help extend oncology patients' lives, study finds

Symptom self-reporting web-based tool could be used to help extend oncology patients' lives, study finds

Electronic patient-reported symptom monitoring increases survival compared with usual cancer care

Electronic patient-reported symptom monitoring increases survival compared with usual cancer care

Online intervention can relieve distress, improve quality of life for cancer patients

Online intervention can relieve distress, improve quality of life for cancer patients

Study finds steady decline in severe health problems for childhood cancer survivors

Study finds steady decline in severe health problems for childhood cancer survivors

Brief psychological intervention reduces depressive symptoms in patients with advanced cancer

Brief psychological intervention reduces depressive symptoms in patients with advanced cancer

CDC warning on Salmonella infections in humans from backyard poultry

CDC warning on Salmonella infections in humans from backyard poultry

New targeted oral therapy results in durable responses across many kinds of cancer

New targeted oral therapy results in durable responses across many kinds of cancer

Positive results for AstraZeneca’s PARP inhibitor Lynparza in advanced breast cancer

Positive results for AstraZeneca’s PARP inhibitor Lynparza in advanced breast cancer

Standard therapy plus abiraterone lowers relative risk of death in men with advanced prostate cancer

Standard therapy plus abiraterone lowers relative risk of death in men with advanced prostate cancer

Study provides reassurance to breast cancer survivors who contemplate pregnancy

Study provides reassurance to breast cancer survivors who contemplate pregnancy

Study finds higher risk of fractures among older, long-term bisphosphonate users

Study finds higher risk of fractures among older, long-term bisphosphonate users

Combination therapy shows potential for effective treatment of RAS-mutant cancers

Combination therapy shows potential for effective treatment of RAS-mutant cancers

Patients nearing end of life may not feel abandoned after discontinuation of cholesterol medications

Patients nearing end of life may not feel abandoned after discontinuation of cholesterol medications

Genetic sequencing could help direct treatment for 72% of advanced cancer patients

Genetic sequencing could help direct treatment for 72% of advanced cancer patients

Changes in immune activity appear to signal brain tumor growth five years before diagnosis, study finds

Changes in immune activity appear to signal brain tumor growth five years before diagnosis, study finds

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.